Ankush Chandra, MD

Resident Physician
UT Houston Department of Neurological Surgery

Ankush Chandra, MD is a PGY-5 Neurosurgery resident at the University of Texas Health Science Center at Houston with a keen interest in neurosurgical oncology. He is an NIH R25/UE5 grant recipient and his current research in the Lo laboratory focuses on understanding CDK4/6 inhibitor resistance in glioblastoma and developing novel combination therapies. As an aspiring neurosurgeon-scientist, Dr. Chandra's research interests include studying the tumor microenvironment, aiming to identify novel therapeutic targets and enhance patient outcomes by overcoming resistance mechanisms. His ultimate goal is to translate these findings into clinical practice, improving the prognosis and quality of life for GBM patients through innovative treatments.

Disclosure(s): No financial relationships to disclose

Presentation(s):

• tGLI1 is a Novel Targetable Transcription Factor that Promotes Resistance to CDK4/6 Inhibitors and Chemoradiation in Glioblastoma

  Saturday, April 26, 2025
  8:39 AM – 8:46 AM EDT

• The Path to the Top: Factors Associated With Matching into Top-Tier Neurosurgical Residencies in the U.S.

  Saturday, April 26, 2025
  12:15 PM – 1:30 PM EDT